Cargando…

Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients

PURPOSE: Programmed death-ligand 1 (PD-L1) is found to be overexpressed in non-small cell lung cancer. The present study intended to evaluate the status of PD-L1 expression in patients with resection and recurrent lung adenocarcinoma. PATIENTS AND METHODS: Matched resection and recurrent tumor sampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jun, Li, Hui, Pang, Ronglin, Huang, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388238/ https://www.ncbi.nlm.nih.gov/pubmed/28435290 http://dx.doi.org/10.2147/OTT.S127498

Ejemplares similares

The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma
por: Wu, Shafei, et al.
Publicado: (2017)

Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma
por: Song, Zhengbo, et al.
Publicado: (2016)

Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

A CT-derived deep neural network predicts for programmed death ligand-1 expression status in advanced lung adenocarcinomas
por: Zhu, Ying, et al.
Publicado: (2020)

Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma in situ and minimally invasive adenocarcinoma of lung
por: Yu, Renke, et al.
Publicado: (2017)

Correlation between Programmed Death-1 Ligand-1 and p53 in Patients with Lung Adenocarcinoma
por: Xu, Cheng, et al.
Publicado: (2018)

Clinicopathological characteristics correlated with programmed cell death-ligand 1 expression in advanced lung adenocarcinoma
por: Gao, Hengxing, et al.
Publicado: (2023)

Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
por: Li, Kang, et al.
Publicado: (2022)

Status of programmed death-ligand 1 expression in sarcomas
por: Park, Hyung Kyu, et al.
Publicado: (2018)

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer
por: D’Arcangelo, Manolo, et al.
Publicado: (2019)

Significance of programmed death‐ligand 1 expression in resected lung cancer and its relationship with EGFR mutation
por: Osoegawa, Atsushi, et al.
Publicado: (2023)

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients
por: Wang, Shuo, et al.
Publicado: (2021)

Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers
por: Liang, Sheng-Kai, et al.
Publicado: (2021)

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma
por: Tessier-Cloutier, Basile, et al.
Publicado: (2017)

Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma
por: Im, Dong Jin, et al.
Publicado: (2021)

Preoperative CT Predicting Recurrence of Surgically Resected Adenocarcinoma of the Lung
por: Koo, Hyun Jung, et al.
Publicado: (2016)

Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection
por: He, Chaobin, et al.
Publicado: (2021)

Infiltration of tumor‐associated macrophages is involved in tumor programmed death‐ligand 1 expression in early lung adenocarcinoma
por: Shima, Toshiyuki, et al.
Publicado: (2020)

Programmed Death Ligand-1 Testing in Adenocarcinoma Lung: A Comparative Study of Cell Block versus Biopsy
por: Shukla, Saumya, et al.
Publicado: (2023)

Prognosis of recurrence after complete resection in early-stage lung adenocarcinoma based on molecular alterations: a systematic review and meta-analysis
por: Zhou, Chu, et al.
Publicado: (2023)

Lymphocyte activation gene-3 is associated with programmed death-ligand 1 and programmed cell death protein 1 in small cell lung cancer
por: Sun, Hui, et al.
Publicado: (2021)

Programmed death-ligand 1 expression in the tumour stroma of colorectal liver oligometastases and its association with prognosis after liver resection
por: Peng, Jian-Hong, et al.
Publicado: (2020)

Preoperative monocyte count is a predictor of recurrence after Stage I lung adenocarcinoma resection
por: Yoshida, Chihiro, et al.
Publicado: (2022)

Five cases of BRAF V600E-mutant lung adenocarcinoma with high expression of programmed death ligand 1
por: Katano, Takuma, et al.
Publicado: (2020)

The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma
por: Hsu, Ping-Chih, et al.
Publicado: (2020)

Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma
por: Kang, Minsu, et al.
Publicado: (2021)

Recurrence benefit from supramarginal resection in brain metastases of lung adenocarcinoma
por: Gong, Weizhao, et al.
Publicado: (2022)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer
por: Kim, Seok-Hyun, et al.
Publicado: (2019)

Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection
por: Kwon, Mi Jung, et al.
Publicado: (2017)

Reappraise role of lymph node status in patterns of recurrence following curative resection of gastric adenocarcinoma
por: Tang, Yihui, et al.
Publicado: (2021)

Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment
por: Hoshimoto, Aitoshi, et al.
Publicado: (2023)

Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection
por: Wu, Yu-Chung, et al.
Publicado: (2017)

Human Leukocyte Antigen Class I and Programmed Death-Ligand 1 Coexpression Is an Independent Poor Prognostic Factor in Adenocarcinoma of the Lung
por: Han, Yeon Bi, et al.
Publicado: (2019)

Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy
por: Jomrich, Gerd, et al.
Publicado: (2021)

Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma()
por: Dai, Xiaomeng, et al.
Publicado: (2017)

Pulmonary adenocarcinoma possibly developed from the cut-end of small-sized adenocarcinoma in the lung periphery as recurrence 13 years after its wedge resection
por: Hanaoka, Takaomi, et al.
Publicado: (2018)

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019)

Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme
por: Heynckes, Sabrina, et al.
Publicado: (2017)

Small bowel adenocarcinoma: natural history of recurrence after surgical resection
por: Farina, Massimo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ukdck85hohsknnngvr2l34lk2r